ReWalk Robotics Ltd. (NASDAQ:RWLK) shares traded down 1% during mid-day trading on Monday . The company traded as low as $6.81 and last traded at $6.96, with a volume of 73,688 shares changing hands. The stock had previously closed at $7.03.

A number of research analysts have recently issued reports on the company. Jefferies Group reiterated a “buy” rating and issued a $16.00 price target on shares of ReWalk Robotics in a report on Sunday, May 8th. Zacks Investment Research upgraded ReWalk Robotics from a “sell” rating to a “hold” rating in a report on Thursday, April 28th. Finally, Piper Jaffray Cos. assumed coverage on ReWalk Robotics in a report on Friday. They issued an “overweight” rating and a $10.00 price target on the stock. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $12.80.

The firm has a 50 day moving average price of $6.88 and a 200-day moving average price of $9.04. The firm’s market capitalization is $86.10 million.

ReWalk Robotics (NASDAQ:RWLK) last released its quarterly earnings data on Thursday, May 5th. The medical device company reported ($0.48) EPS for the quarter, beating analysts’ consensus estimates of ($0.60) by $0.12. The business earned $2.06 million during the quarter, compared to analyst estimates of $1.56 million. The company’s revenue was up 224.6% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.48) earnings per share. Equities analysts expect that ReWalk Robotics Ltd. will post ($2.11) earnings per share for the current fiscal year.

In other ReWalk Robotics news, major shareholder Scp Vitalife Partners (Israel) sold 4,043 shares of the company’s stock in a transaction on Friday, May 20th. The stock was sold at an average price of $9.09, for a total transaction of $36,750.87. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Wayne Weisman sold 16,148 shares of the company’s stock in a transaction on Friday, May 20th. The stock was sold at an average price of $9.09, for a total value of $146,785.32. The disclosure for this sale can be found here.

A hedge fund recently bought a new stake in ReWalk Robotics stock. EAM Investors LLC purchased a new position in ReWalk Robotics Ltd. (NASDAQ:RWLK) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 93,333 shares of the medical device company’s stock, valued at approximately $1,351,000. EAM Investors LLC owned 0.77% of ReWalk Robotics as of its most recent filing with the SEC.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.